Cargando…
Increased Interleukin-36β Expression Promotes Angiogenesis in Japanese Atopic Dermatitis
While atopic dermatitis (AD) is considered as a T helper 2 (Th2)-centered disease, an increase in other types of inflammatory cytokines is also noted in AD and they may also contribute to the development of the disease. Recently, the efficacy of an anti-IL-36 receptor antibody in AD was demonstrated...
Autores principales: | Komaki, Reo, Miyagaki, Tomomitsu, Tanaka, Miho, Nakajima, Kaori, Okano, Tatsuro, Takeuchi, Sora, Kadono, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341928/ https://www.ncbi.nlm.nih.gov/pubmed/37446281 http://dx.doi.org/10.3390/ijms241311104 |
Ejemplares similares
-
Development of Nodular Lesions after Dupilumab Therapy in Erythrodermic Mycosis Fungoides with Interleukin-13 Receptor alpha2 Expression
por: HASHIMOTO, Mina, et al.
Publicado: (2022) -
The ability of biomarkers to assess the severity of atopic dermatitis
por: Nakahara, Takeshi, et al.
Publicado: (2023) -
ORAI1 Genetic Polymorphisms Associated with the Susceptibility of Atopic Dermatitis in Japanese and Taiwanese Populations
por: Chang, Wei-Chiao, et al.
Publicado: (2012) -
Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
por: Lytvyn, Yuliya, et al.
Publicado: (2023) -
Increased Regulatory T Cells and Decreased Myeloid-Derived Suppressor Cells Induced by High CCL17 Levels May Account for Normal Incidence of Cancers among Patients with Atopic Dermatitis
por: Morimura, Sohshi, et al.
Publicado: (2021)